BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Policy

  Merck & Co., Inc. Dealt Another Setback as FDA Rejects Anesthesia Drug Again

  September 23, 2013

   · 

  4 min read
• Drug Development

  Alnylam Pharmaceuticals’s Gene Therapy Shows Strong Efficacy Data in Phase 1 Study

  September 23, 2013

   · 

  16 min read
• Policy

  FDA Accuses USV of Fudging Data

  September 23, 2013

   · 

  1 min read
• Deals

  Veracyte, Inc. Files for $75 Million IPO

  September 23, 2013

   · 

  2 min read
• Genetown

  RainDance Technologies Snags $35 Million in Financing

  September 23, 2013

   · 

  4 min read
• Policy

  SEC Sues Imaging Diagnostic Systems and Top Execs Amid Failed FDA Bids and IRS Issues

  September 23, 2013

   · 

  1 min read
• BioMidwest

  Medtronic, Inc.'s AdaptivCRT Cuts Nearly 50 Percent of Atrial Fibrillation Risk in Heart Failure Patients

  September 23, 2013

   · 

  1 min read
• Business

  AngioDynamics Extends Licensing Agreement With Interface Biologics to Include Central Venous Catheters (CVCs)

  September 23, 2013

   · 

  1 min read
• Drug Development

  OncoMed Pharmaceuticals, Inc. to Present Phase 1a Data in Advanced Solid Tumor Patients for the First-in-Class WNT-Pathway-Targeting Antibody Vantictumab (OMP-18R5) at the European Cancer Congress 2013 (ECC 2013)

  September 23, 2013

   · 

  1 min read
• Deals

  Isotechnika Pharma Inc. and Aurinia Complete Merger and Financing

  September 23, 2013

   · 

  1 min read